Since BRCA1-deficient breast tumor cells have reduced production of dsDNA fragments upon PARPi in the presence of TEMs/TAMs, we wondered whether an exogenous STING agonist could alter macrophage state and tumor cell response to PARPi. Here, STING1 is linked to breast neoplasm.